WuXi STA snaps up Bristol Myers Squibb facility, plants feet in European CDMO marketplace
A WuXi AppTech spinoff will finally have a European facility under its belt after buying up a Bristol Myers Squibb site, the company announced Tuesday.
WuXi STA, which launched as a CDMO in 2003, will acquire Bristol Myers Squibb’s site in Couvet, Switzerland that specializes in commercial-scale production of various capsules and tablet dosage forms. The company said in a press release it will both enhance and grow its manufacturing capacities through a “world-class” facility.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.